| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |